Statin prescription rates vary by age in dyslipidemia patients Prescription rates for statins were dependent on age among patients with severe dyslipidemia. Statin prescription rates among patients ...

Physician “nudges” via electronic health record prompts and peer comparison feedback improved statin prescription in the primary care setting for eligible patients compared with usual care, ...

CHICAGO - New guidelines on heart health that sparked fierce debate among U.S. cardiologists last fall could lead 12.8 million more Americans to take cholesterol-lowering statin drugs, U.S.

The American Heart Association’s new cardiovascular disease event prediction equations could leave 14.3 million patients ineligible for statin therapy, according to a study published July 29 in JAMA.

A new risk assessment for heart disease found that 40% fewer people would meet the criteria for a statin prescription, NBC News reported June 11. A study, published by researchers at the University of ...

Expanding prescription of statin medication to reduce low-density lipoprotein cholesterol could be a cost-effective intervention against cardiovascular disease, according to a Northwestern Medicine ...

When it comes to using statins to prevent a first heart attack or stroke, one leading US guideline recommends the drugs to 9 million more people than the other, according to a study published in the ...

Diabetics learn to keep a close watch on their blood sugar. New guidelines say they need to keep just as close an eye on their cholesterol. Find out what physicians are learning about keeping ...

Statins are under-prescribed in patients with type 2 diabetes who are receiving anti-hyperglycemic agents, according to an analysis of medical records from a large database. The results show that ...

A new way of determining heart disease risk may result in millions fewer people getting prescriptions for statins, according to new research. Heart doctors warned, however, that more information is ...

The measurement of LDL-cholesterol levels should be reintroduced as a performance metric to improve population-wide lipid control, lower the risk of cardiovascular morbidity and mortality, and promote ...